|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-12-2
|
|
pubmed:abstractText |
Chronic liver disease and intravenous (i.v.) iron therapy can enhance oxidative stress. The aim of this study was to assess the influence of hepatitis C virus (HCV) and i.v. iron administration on oxidative stress in chronic haemodialysis (HD) patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
pubmed-author:BruchfeldAnnetteA,
pubmed-author:HayashiShirley YSY,
pubmed-author:LindholmBengtB,
pubmed-author:ManfroRoberto CRC,
pubmed-author:NascimentoMarcelo MMM,
pubmed-author:PachalyMaria AMA,
pubmed-author:Pecoits-FilhoRobertoR,
pubmed-author:QureshiAbdul RashidAR,
pubmed-author:RennerLucianaL,
pubmed-author:RiellaMiguel CMC,
pubmed-author:StenvinkelPeterP,
pubmed-author:SulimanMohamed EME
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3112-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15466879-Arginine,
pubmed-meshheading:15466879-Female,
pubmed-meshheading:15466879-Ferritins,
pubmed-meshheading:15466879-Hepatitis C,
pubmed-meshheading:15466879-Humans,
pubmed-meshheading:15466879-Iron,
pubmed-meshheading:15466879-Kidney Failure, Chronic,
pubmed-meshheading:15466879-Lysine,
pubmed-meshheading:15466879-Male,
pubmed-meshheading:15466879-Middle Aged,
pubmed-meshheading:15466879-Oxidative Stress,
pubmed-meshheading:15466879-Renal Dialysis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients.
|
|
pubmed:affiliation |
Faculdade Evangélica de Medicina do Paraná-Brazil.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
